Not all the research points to EBV. HERVs could be also involved.
"Preclinical  research demonstrated that pathogenic  HERV-W  protein negatively impacts  myelin  restoration  by  directly inhibiting oligodendrocyte  precursor  cells (OPC), and induces  inflammation  by microglia activation"
"The retroviral   envelope  protein,  encoded   by   a pathogenic  member  of  the  HERV-W  family  (pHERV-W  env)  has  been identified  in brain  lesions  of patients with MS, particularly in active lesions, and in the pancreas of type 1 diabetes (T1D) patients"
Source
http://www.geneuro.com/data/news/geneur ... -ms-en.pdf
			
			
									
						
										
						Human endogenous retro-viruses HERVs and link to diabetes
Re: Human endogenous retro-viruses HERVs and link to diabete
Answering to myself, it seems that the HERVs retroviruses activation could be due to EBV. Therefore, it seems that all the evidence about HERV-W also points indirectly to EBV.
http://www.nrronline.org/article.asp?is ... ulast=Guan
... HERV-W activity (measured by MSRV-type transcript expression in peripheral blood mononuclear cells, PBMC) was higher in patients with infectious mononucleosis, and in healthy controls with high anti-EBV antibodies (Mameli et al., 2013). These findings suggest that silent MSRV may be activated by environmental triggers, such as an EBV infection, to directly contribute to MS development (Kury et al., 2018). Future studies are required for a better understanding of the role of MSRV and its interaction with EBV in the MS pathogenesis.
			
			
									
						
										
						http://www.nrronline.org/article.asp?is ... ulast=Guan
... HERV-W activity (measured by MSRV-type transcript expression in peripheral blood mononuclear cells, PBMC) was higher in patients with infectious mononucleosis, and in healthy controls with high anti-EBV antibodies (Mameli et al., 2013). These findings suggest that silent MSRV may be activated by environmental triggers, such as an EBV infection, to directly contribute to MS development (Kury et al., 2018). Future studies are required for a better understanding of the role of MSRV and its interaction with EBV in the MS pathogenesis.